Just Crazy Thoughts of Crazy GainsStock showing Buying Power recent days.
Each Take Profit Line is where you may secure profit and run.
Re-testing the Green Zone 4H with Buyers Step-in is perfect.
Maybe we may not re-test it current price close at Support Level if it held for next session.
I believe we will see Gains of 500-1000%.
Each Line acts as Resistance level that worth watching with 15 TF in case any selling pressure secure profit is priority.
Note: 1- Potentional of Strong Buying Zone:
We have two scenarios must happen at The Mentioned Zone:
Scenarios One: strong buying volume with reversal Candle.
Scenarios Two: Fake Break-Out of The Buying Zone.
Both indicate buyers stepping in strongly. NEVER Join in unless one showed up.
2- How to Buy Stock:
On 15M TF when Marubozu Candle show up which indicate strong buyers stepping-in.
Buy on 0.5 Fibo Level of the Marubozu Candle, because price will always and always re-test the imbalance.
PLTR – Structure Holding… For Now (4H Outlook)Palantir is compressing near ATHs, but showing early signs of exhaustion on higher timeframes. On the 4H chart, structure is still bullish — but fragile.
🔍 Key Technical Structure
• Series of Breaks of Structure (BoS) confirming the bullish trend
• Price is currently sitting above the $125 4H demand zone, near previous highs
• Invalidation for the bearish thesis sits at $140
🧭 Strategy Outlook
If $125.50 fails:
→ Next demand: $113.00–$105.00
→ Below that: strong support zone at $98.00–$89.00
If $140 breaks and holds:
→ Bearish divergence invalidated
→ Continuation toward new highs likely
📌 Summary
Price is at an inflection point. Structure remains bullish, but momentum is weakening across higher timeframes and RSI divergence is still active.
Watching $125.50 as the trigger:
Below = potential sell-off
Above = stay patient
BMY BullishSo many things to like about this current setup. Aside from a strong advanced decline line allowing the baton to be passed to other names to further participate in the melt up rally...
Divergence with the RSI showing the true bottom and now there is a volume shelf setup which triggers just around $51. A break above that will also be met with a VWAP as resistance so that is a key level. Also, gap fill at $57 which just happens to be right below top of volume shelf at $59. On high way for a large upside move considering BMY has a beta of about .60
LMT Bull rally NOW LMT has seen major consolidation in the last month. Analysis agrees that although a rough match was felt with recent US shorting orders this was a minor bump on the road since many other project are abead and other kitties such as Germany and Italy are ramlling up defense and air capabilities. LMT is going towards $520 by next week.
Possible Breakout Alert: Barrick Gold (B) - Inverse H&S in Play🚨 Possible Breakout Alert: Barrick Gold (B) – Inverse H&S in Play 🚨
Barrick (NYSE: B) looks poised for a technical breakout from a well-formed inverse head & shoulders pattern that’s been building for months.
Key Levels:
Neckline: ~$20.90–$21.13 zone now being tested
Breakout Target: $24.50+
Support Zones: $19.50 / $18.22 / $17.48
Confluence:
RSI has reset and is curling up
Volume is rising into resistance
Price reclaiming key MAs
Macro tailwinds in the metals space
📈 My Positioning:
I built into this move over time, scaling in during flushes. Current options exposure:
Jan 2026 $15C – Already deep in the money
Jan & Dec 2026 $20C – Showing strong gains
Dec 2026 $35C – Long-dated lottos for a gold breakout scenario
The structure is there. The setup is clear. All eyes on the weekly close. If B starts clearing $21.13 with authority, this could run quickly.
Sometimes the best trades are the ones you quietly build while everyone else is distracted.
#Barrick #GoldStocks #HNSBreakout #TechnicalAnalysis #Metals #OptionsTrading #TradingView
retrace to 105-110 likely after "Advancing AI" event wraps todayAMD has not had a significant retrace since the bottom on 4-21-2025 and is overdue for one.
AMD stock dropped ~4% after the previous "Advancing AI" event on 10-10-2024, and went into correction over a 2 week period following.
Note that AMD stock did not sustain positive momentum today after the Saudi Arabia cloud news, lending more weight to buyer exhaustion in the short term.
Rocket (RKLB) From Launch Innovator to Space Systems PowerhouseCompany Evolution:
Rocket Lab NASDAQ:RKLB is transforming into a vertically integrated space and defense systems company, leveraging its launch heritage to build long-term, diversified revenue streams.
Key Catalysts:
Rapid Launch Cadence 🛰️
3 Electron launches in 24 days demonstrate operational agility and scalability.
Meets rising demand for high-frequency satellite constellation deployments.
Strategic GEOST Acquisition 🛡️
$275M deal expands into electro-optical and infrared payloads, key for defense/ISR.
Boosts margin profile, backlog durability, and government contract appeal.
Validated Execution & Recurring Revenue 💼
100% mission success rate and multi-launch contract with Japan's iQPS reinforce credibility.
Positions RKLB for long-term cash flow stability and multiyear contract wins.
Investment Outlook:
📈 Bullish above $23.00–$24.00, backed by high reliability and strategic expansion.
🎯 Price Target: $42.00–$43.00, reflecting an expanding TAM, defense sector momentum, and vertically integrated execution.
🌠 RKLB is no longer just reaching orbit—it's building the infrastructure of space. #RKLB #SpaceStocks #DefenseGrowth
PFIZER INC. (NYSE)For all vaccine enthusiasts, Pfizer shares are currently among the best options.
At the time of publication, the price is holding steady at $24.83 . Our forecast is that the price will rise to $27.48 (minimum)! Most likely by August.
Personally, I don't trade stocks, as I have decided to change my market preference, but I can say that if I were Warren Buffett , I would recommend buying it.
✅ The price is low.
✅ The brand is well-known.
✅ Pharmaceuticals is a profitable sector of the economy, on par with IT and other new technologies.
$GTLB: AI SaaS Software stock for tactical and long-term tradeIn this blog space we focus a lot on the AI trade. Be it semiconductors, AI powered Cybersecurity, AI Powered Fintech or just the industry itself, but we have not quietly focused on the AI Software stocks. The second and third derivatives of the AI trade will be more on the software space than Semiconductors where most of the future value will be accrued. Now within the AI Software space we have discussed NASDAQ:CRWD strike as one of our favorites, but can there be other names which can give us a lot of Alpha in the near and long term?
In my opinion NASDAQ:GTLB is one such stock. Gitlab provides software developers productivity tools to develop software faster, better and securely. Coming back to the technical below we can see that lately the stock is stuck within the upward sloping channel on the weekly chart since the bear market lows of 2023. If we plot the Fib retracement level from the all-time highs to the all-time lows, we can see that on the weekly chart it is stuck below the 0.236 Fib level with an oversold RSI. But the recent price action indicates that even if we touched the lower bound of the price we saw after April 4 Lib Day lows, we are still holding an RSI of 41 indicating seller exhaustion. So, the next levels in the chart are 52 $ then 67 $ and then 80 $ in the medium term, which is well within the parallel channel.
Verdict: NASDAQ:GTLB target prices are 52 $ then 67 $ and then 80 $. Can be held for long term returns.
Visa: Resistance ApproachingThe next key step for Visa should be overcoming resistance at $394.49 during magenta wave . However, if support at $339.61 fails to hold, our alternative scenario (33% probability) will be activated—suggesting the recent high already marked the end of the corrective wave alt. in magenta. In that case, a renewed decline below the $299 mark would be likely, aiming to complete the alternative turquoise wave alt.4 on a larger scale.
📈 Over 190 precise analyses, clear entry points, and defined Target Zones - that's what we do.
Novartis | NVS | Long at $99.00As one of the largest pharmaceutical companies in the world, Novartis NYSE:NVS is poised to grow well into 2027. It's trading at a 17x P/E, earnings are forecast to grow 7% per year, it has low debt, and has been raising its dividend over the past few years (3.8%). The price on the daily chart is nearing the historical simple moving average line and may be poised for another move up. However, entry into the lower $90's or even $80's is still not off the table and, in my view, a great opportunity. Thus, at $99.00, NYSE:NVS is in a personal buy zone.
Target #1 = $110.00
Target #2 = $120.00
AMC Entertainment Holdings | AMC | Long at $3.66First, I'm not an " NYSE:AMC APE" and have zero interest in becoming one. Second, don't trade NYSE:AMC unless you are fully aware the investment could go to zero or the company may devalue your trade via share dilution or other means (i.e., don't simply do as I do or blindly follow anyone else's moves, for the matter).
With that aside, I started a position/gambling play today in NYSE:AMC at $3.66. The reason is 80% technical analysis and 20% fundamentals.
Technical Analysis:
The blue line on the chart represents an average true range (ATR) from a historical simple moving average (SMA) that I use for trading. For simplicity, the historical SMA is not show on the chart - just the ATR. This blue ATR line has historically been a major line of resistance and support. When it breaks through and holds, the stock goes bull - but history may not repeat. The price recently broke the blue ATR line, fell below, and the broke out again today. This may be a sign that the downward trend (overall) is changing - perhaps furthering the accumulation phase in the $3s or a gradual rise from here. And with today's breakout, I grabbed shares at $3.66.
Fundamentals
Since 2020, NYSE:AMC has shown major gains in revenue and net income (loss reduction, that is). Revenu: $1.24 billion (2020); $2.53 billion (2021); $3.91 billion (2022); 4.81 billion (2023); $4.4 billion (2024, Q1-3 only). Net Income: -$4.5 billion (2020); -$1.27 billion (2021); -$973 million (2022); -$396 million (2023); -$399 million (2024, Q1-3 only). The company is not expected to become profitable until Q4 of 2026 , but the improvements are what one would like to see.
Counter-arguments and statements the stock is junk are totally valid. But the chart is quite interesting as the company moves toward profitability (maybe...).
Targets:
$4.30
$6.00
Squeeze/mass hysteria: $18.00, $40.00, and ridiculousness: $85.00
BRK.B Long The stock has been trading within a defined channel for nearly five years, suggesting it may be approaching a pivotal bottom. If this turns out to be the case, we could have the opportunity to acquire additional shares of this outstanding company at more attractive prices. It's crucial to stay vigilant and monitor any developments related to this stock, as market conditions can change rapidly. By keeping a close watch on the company's performance and any news that may impact its valuation, we can capitalize on potential buying opportunities that arise. Investing in a fundamentally strong company at lower price points could significantly benefit our long-term investment strategy.